Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration

A. Deljou, S. J. Hedrick, E. R. Portner, D. R. Schroeder, W. M. Hooten, J. Sprung, T. N. Weingarten

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Single preoperative gabapentinoid (gabapentin and pregabalin) administration has been associated with respiratory depression during Phase I anaesthesia recovery. In this study, we assess for associations between chronic (home) use and perioperative administration (preoperative and postoperative) of gabapentinoids, and risk for severe over-sedation or respiratory depression as inferred from the use of naloxone. Methods: From 2011 to 2016, we identified patients undergoing general anaesthesia discharged to standard postoperative wards and administered naloxone within 48 h of surgery in a single centre. These patients were 2:1 matched on age, sex, and type of procedure. Patient and perioperative characteristics were abstracted and compared to assess for risk for naloxone administration. Results: We identified 128 patients that received naloxone after operation [odds ratio 1.2; 95% confidence interval (CI) 1.0, 1.4 per 1000 general anaesthetics]. Patients on chronic or postoperative gabapentinoid therapy were at significantly higher risk for receiving naloxone after operation. Multivariable analysis detected significant interactions between chronic and postoperative use of gabapentinoids, where continuation of chronic gabapentinoid medications into the postoperative period was associated with an increased rate of naloxone administration (6.30, 95% CI 2.4, 16.7; P=0.001). Obstructive sleep apnoea (P=0.005) and preoperative disability (P=0.003) were also associated with an increased risk for postoperative naloxone administration. Patients who received naloxone had longer hospital stays and higher rates of postoperative delirium. Conclusions: Continuation of chronic gabapentinoid medications into the postoperative period is associated with the increased use of naloxone to reverse over-sedation or respiratory depression. Such patients requiring this therapy warrant high levels of postoperative monitoring.

Original languageEnglish (US)
Pages (from-to)798-806
Number of pages9
JournalBritish Journal of Anaesthesia
Volume120
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Naloxone
Respiratory Insufficiency
Postoperative Period
Confidence Intervals
General Anesthetics
Delirium
Obstructive Sleep Apnea
General Anesthesia
Length of Stay
Anesthesia
Odds Ratio
Therapeutics

Keywords

  • gabapentin
  • naloxone
  • postoperative complications

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Deljou, A., Hedrick, S. J., Portner, E. R., Schroeder, D. R., Hooten, W. M., Sprung, J., & Weingarten, T. N. (2018). Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration. British Journal of Anaesthesia, 120(4), 798-806. https://doi.org/10.1016/j.bja.2017.11.113

Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration. / Deljou, A.; Hedrick, S. J.; Portner, E. R.; Schroeder, D. R.; Hooten, W. M.; Sprung, J.; Weingarten, T. N.

In: British Journal of Anaesthesia, Vol. 120, No. 4, 01.04.2018, p. 798-806.

Research output: Contribution to journalArticle

Deljou, A, Hedrick, SJ, Portner, ER, Schroeder, DR, Hooten, WM, Sprung, J & Weingarten, TN 2018, 'Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration', British Journal of Anaesthesia, vol. 120, no. 4, pp. 798-806. https://doi.org/10.1016/j.bja.2017.11.113
Deljou, A. ; Hedrick, S. J. ; Portner, E. R. ; Schroeder, D. R. ; Hooten, W. M. ; Sprung, J. ; Weingarten, T. N. / Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration. In: British Journal of Anaesthesia. 2018 ; Vol. 120, No. 4. pp. 798-806.
@article{53a7f73ac9d24f3280739c46c9dfcb05,
title = "Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration",
abstract = "Background: Single preoperative gabapentinoid (gabapentin and pregabalin) administration has been associated with respiratory depression during Phase I anaesthesia recovery. In this study, we assess for associations between chronic (home) use and perioperative administration (preoperative and postoperative) of gabapentinoids, and risk for severe over-sedation or respiratory depression as inferred from the use of naloxone. Methods: From 2011 to 2016, we identified patients undergoing general anaesthesia discharged to standard postoperative wards and administered naloxone within 48 h of surgery in a single centre. These patients were 2:1 matched on age, sex, and type of procedure. Patient and perioperative characteristics were abstracted and compared to assess for risk for naloxone administration. Results: We identified 128 patients that received naloxone after operation [odds ratio 1.2; 95{\%} confidence interval (CI) 1.0, 1.4 per 1000 general anaesthetics]. Patients on chronic or postoperative gabapentinoid therapy were at significantly higher risk for receiving naloxone after operation. Multivariable analysis detected significant interactions between chronic and postoperative use of gabapentinoids, where continuation of chronic gabapentinoid medications into the postoperative period was associated with an increased rate of naloxone administration (6.30, 95{\%} CI 2.4, 16.7; P=0.001). Obstructive sleep apnoea (P=0.005) and preoperative disability (P=0.003) were also associated with an increased risk for postoperative naloxone administration. Patients who received naloxone had longer hospital stays and higher rates of postoperative delirium. Conclusions: Continuation of chronic gabapentinoid medications into the postoperative period is associated with the increased use of naloxone to reverse over-sedation or respiratory depression. Such patients requiring this therapy warrant high levels of postoperative monitoring.",
keywords = "gabapentin, naloxone, postoperative complications",
author = "A. Deljou and Hedrick, {S. J.} and Portner, {E. R.} and Schroeder, {D. R.} and Hooten, {W. M.} and J. Sprung and Weingarten, {T. N.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.bja.2017.11.113",
language = "English (US)",
volume = "120",
pages = "798--806",
journal = "British Journal of Anaesthesia",
issn = "0007-0912",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration

AU - Deljou, A.

AU - Hedrick, S. J.

AU - Portner, E. R.

AU - Schroeder, D. R.

AU - Hooten, W. M.

AU - Sprung, J.

AU - Weingarten, T. N.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Background: Single preoperative gabapentinoid (gabapentin and pregabalin) administration has been associated with respiratory depression during Phase I anaesthesia recovery. In this study, we assess for associations between chronic (home) use and perioperative administration (preoperative and postoperative) of gabapentinoids, and risk for severe over-sedation or respiratory depression as inferred from the use of naloxone. Methods: From 2011 to 2016, we identified patients undergoing general anaesthesia discharged to standard postoperative wards and administered naloxone within 48 h of surgery in a single centre. These patients were 2:1 matched on age, sex, and type of procedure. Patient and perioperative characteristics were abstracted and compared to assess for risk for naloxone administration. Results: We identified 128 patients that received naloxone after operation [odds ratio 1.2; 95% confidence interval (CI) 1.0, 1.4 per 1000 general anaesthetics]. Patients on chronic or postoperative gabapentinoid therapy were at significantly higher risk for receiving naloxone after operation. Multivariable analysis detected significant interactions between chronic and postoperative use of gabapentinoids, where continuation of chronic gabapentinoid medications into the postoperative period was associated with an increased rate of naloxone administration (6.30, 95% CI 2.4, 16.7; P=0.001). Obstructive sleep apnoea (P=0.005) and preoperative disability (P=0.003) were also associated with an increased risk for postoperative naloxone administration. Patients who received naloxone had longer hospital stays and higher rates of postoperative delirium. Conclusions: Continuation of chronic gabapentinoid medications into the postoperative period is associated with the increased use of naloxone to reverse over-sedation or respiratory depression. Such patients requiring this therapy warrant high levels of postoperative monitoring.

AB - Background: Single preoperative gabapentinoid (gabapentin and pregabalin) administration has been associated with respiratory depression during Phase I anaesthesia recovery. In this study, we assess for associations between chronic (home) use and perioperative administration (preoperative and postoperative) of gabapentinoids, and risk for severe over-sedation or respiratory depression as inferred from the use of naloxone. Methods: From 2011 to 2016, we identified patients undergoing general anaesthesia discharged to standard postoperative wards and administered naloxone within 48 h of surgery in a single centre. These patients were 2:1 matched on age, sex, and type of procedure. Patient and perioperative characteristics were abstracted and compared to assess for risk for naloxone administration. Results: We identified 128 patients that received naloxone after operation [odds ratio 1.2; 95% confidence interval (CI) 1.0, 1.4 per 1000 general anaesthetics]. Patients on chronic or postoperative gabapentinoid therapy were at significantly higher risk for receiving naloxone after operation. Multivariable analysis detected significant interactions between chronic and postoperative use of gabapentinoids, where continuation of chronic gabapentinoid medications into the postoperative period was associated with an increased rate of naloxone administration (6.30, 95% CI 2.4, 16.7; P=0.001). Obstructive sleep apnoea (P=0.005) and preoperative disability (P=0.003) were also associated with an increased risk for postoperative naloxone administration. Patients who received naloxone had longer hospital stays and higher rates of postoperative delirium. Conclusions: Continuation of chronic gabapentinoid medications into the postoperative period is associated with the increased use of naloxone to reverse over-sedation or respiratory depression. Such patients requiring this therapy warrant high levels of postoperative monitoring.

KW - gabapentin

KW - naloxone

KW - postoperative complications

UR - http://www.scopus.com/inward/record.url?scp=85045955760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045955760&partnerID=8YFLogxK

U2 - 10.1016/j.bja.2017.11.113

DO - 10.1016/j.bja.2017.11.113

M3 - Article

VL - 120

SP - 798

EP - 806

JO - British Journal of Anaesthesia

JF - British Journal of Anaesthesia

SN - 0007-0912

IS - 4

ER -